Hepatitis B (Dutch Wikipedia)

Analysis of information sources in references of the Wikipedia article "Hepatitis B" in Dutch language version.

refsWebsite

Global rank Dutch rank

12nih.gov

4^th place

12^th place

7doi.org

2^nd place

8^th place

5archive.org

6^th place

25^th place

1nature.com

234^th place

128^th place

1osap.org

low place

1web.archive.org

1^st place

archive.org

Lok AS, McMahon BJ (2007). Chronic hepatitis B. Hepatology 45 (2): 507–39. PMID 17256718. DOI: 10.1002/hep.21513.
Chu CM, Liaw YF (2007). Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B. Gastroenterology 133 (5): 1458–65. PMID 17935720. DOI: 10.1053/j.gastro.2007.08.039.
Petersen NJ, Barrett DH, Bond WW, Berquist KR, Favero MS, Bender TR, Maynard JE (1976). Hepatitis B surface antigen in saliva, impetiginous lesions, and the environment in two remote Alaskan villages. Appl. Environ. Microbiol. 32 (4): 572-574. PMID 791124.
Alter MJ (2003). Epidemiology and prevention of hepatitis B. Semin. Liver Dis. 23 (1): 39-46. PMID 12616449. DOI: 10.1055/s-2003-37583.
Hollinger FB, Lau DT (2006). Hepatitis B: the pathway to recovery through treatment. Gastroenterol. Clin. North Am. 35 (4): 895–931. PMID 17129820. DOI: 10.1016/j.gtc.2006.10.002.

doi.org

Kerkar N (2005). Hepatitis B in children: complexities in management. Pediatric transplantation 9 (5): 685–91. PMID 16176431. DOI: 10.1111/j.1399-3046.2005.00393.x.
Iannacone M, Sitia G, Ruggeri ZM, Guidotti LG (2007). HBV pathogenesis in animal models: recent advances on the role of platelets. J. Hepatol. 46 (4): 719–26. PMID 17316876. DOI: 10.1016/j.jhep.2007.01.007.
Lok AS, McMahon BJ (2007). Chronic hepatitis B. Hepatology 45 (2): 507–39. PMID 17256718. DOI: 10.1002/hep.21513.
Chu CM, Liaw YF (2007). Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B. Gastroenterology 133 (5): 1458–65. PMID 17935720. DOI: 10.1053/j.gastro.2007.08.039.
Alter MJ (2003). Epidemiology and prevention of hepatitis B. Semin. Liver Dis. 23 (1): 39-46. PMID 12616449. DOI: 10.1055/s-2003-37583.
Hollinger FB, Lau DT (2006). Hepatitis B: the pathway to recovery through treatment. Gastroenterol. Clin. North Am. 35 (4): 895–931. PMID 17129820. DOI: 10.1016/j.gtc.2006.10.002.
Hui CK, Lau GK (2005). Peginterferon-alpha2a (40 kDa) (Pegasys) for hepatitis B. Expert review of anti-infective therapy 3 (4): 495–504. PMID 16107195. DOI: 10.1586/14787210.3.4.495.

nature.com

Iannacone M, Sitia G, Isogawa M, Marchese P, Castro M, Lowenstein P, Chisari F, Ruggeri Z, Guidotti L (2005). Platelets mediate cytotoxic T lymphocyte-induced liver damage. Nature Medicine 11 (11): 1167-1169. PMID 16258538.

nih.gov

ncbi.nlm.nih.gov

Kerkar N (2005). Hepatitis B in children: complexities in management. Pediatric transplantation 9 (5): 685–91. PMID 16176431. DOI: 10.1111/j.1399-3046.2005.00393.x.
Iannacone M, Sitia G, Ruggeri ZM, Guidotti LG (2007). HBV pathogenesis in animal models: recent advances on the role of platelets. J. Hepatol. 46 (4): 719–26. PMID 17316876. DOI: 10.1016/j.jhep.2007.01.007.
Iannacone M, Sitia G, Isogawa M, Marchese P, Castro M, Lowenstein P, Chisari F, Ruggeri Z, Guidotti L (2005). Platelets mediate cytotoxic T lymphocyte-induced liver damage. Nature Medicine 11 (11): 1167-1169. PMID 16258538.
Bonino F, Chiaberge E, Maran E, Piantino P (1987). Serological markers of HBV infectivity. Ann. Ist. Super. Sanita 24 (2): 217–23. PMID 3331068.
Lok AS, McMahon BJ (2007). Chronic hepatitis B. Hepatology 45 (2): 507–39. PMID 17256718. DOI: 10.1002/hep.21513.
Chu CM, Liaw YF (2007). Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B. Gastroenterology 133 (5): 1458–65. PMID 17935720. DOI: 10.1053/j.gastro.2007.08.039.
Petersen NJ, Barrett DH, Bond WW, Berquist KR, Favero MS, Bender TR, Maynard JE (1976). Hepatitis B surface antigen in saliva, impetiginous lesions, and the environment in two remote Alaskan villages. Appl. Environ. Microbiol. 32 (4): 572-574. PMID 791124.
Shapiro CN (1993). Epidemiology of hepatitis B. Pediatr. Infect. Dis. J. 12 (5): 433–7. PMID 8392167.
Alter MJ (2003). Epidemiology and prevention of hepatitis B. Semin. Liver Dis. 23 (1): 39-46. PMID 12616449. DOI: 10.1055/s-2003-37583.
Hollinger FB, Lau DT (2006). Hepatitis B: the pathway to recovery through treatment. Gastroenterol. Clin. North Am. 35 (4): 895–931. PMID 17129820. DOI: 10.1016/j.gtc.2006.10.002.
Lai CL, Yuen MF (2007). The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points. Ann. Intern. Med. 147 (1): 58–61. PMID 17606962.
Hui CK, Lau GK (2005). Peginterferon-alpha2a (40 kDa) (Pegasys) for hepatitis B. Expert review of anti-infective therapy 3 (4): 495–504. PMID 16107195. DOI: 10.1586/14787210.3.4.495.

osap.org

Redd JT, Baumbach J, Kohn W, et al. (2007). Patient-to-patient transmission of hepatitis B virus associated with oral surgery (PDF). J Infect Dis 195 (9): 1311–4. Geraadpleegd op 12 december 2007.

web.archive.org

February 25, 2005. [https://web.archive.org/web/20080603051848/http://www.roche.com/med-cor-2005-02-25 Pegasys approved in the European Union for the treatment of chronic hepatitis B: Only pegylated interferon approved for the treatment of chronic hepatitis B Retrieved on September 11, 2007.